HEALTHWPLG LOCAL 10 MIAMI
FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
The FDA's upcoming peptide safety review panel includes health professionals with financial ties to the peptide industry, a shift from previous academic-focused panels. The meeting, influenced by Health Secretary Robert F. Kennedy Jr.'s 'Make America Healthy Again' movement, will assess peptides like BPC-157 and TB-500, which the FDA has warned are unproven and risky.
Mentioned
Related Signal
Adjacent reporting
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
- FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
- STAT+: Longevity, wellness physicians named to panel advising FDA on peptides
- FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures
- Peptides may soon be easier to get amid RFK Jr's push, but experts warn of risks